[Construction of a DNA vaccine against human B cell lymphoma]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 Jan;20(1):79-82.
[Article in Chinese]

Abstract

Aim: To construct a DNA vaccine based on surface Ig V(H) gene of tumor cells in the human B-cell lymphoma biopsy tissue.

Methods: The V(H) gene fragment was amplified by RT-PCR using Ig superfamily primers. Also, the murine monocyte chemotactic protein 3(MCP-3) cDNA was cloned. The fusion gene fragment of MCP-3 gene with V(H) gene was constructed by recombinant PCR and then cloned into the eukaryotic expression vector pcDNA3.1 to construct the DNA vaccine plasmid pcDNA3.1/MCP-V(H). The vaccine plasmid was transiently expressed in the eukaryotic cell line COS-7.

Results: The DNA vaccine plasmid was successfully constructed and expressed in COS-7 cells in the form of fusion protein MCP-V(H).

Conclusion: The DNA vaccine plasmid pcDNA3.1/MCP-V(H) is constructed and expressed successfully, which plays the foundation for further experimental research in animal model.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • COS Cells
  • Cancer Vaccines / immunology*
  • Chemokine CCL7
  • Cytokines*
  • Humans
  • Immunoglobulin Heavy Chains / genetics*
  • Immunoglobulin Variable Region / genetics*
  • Lymphoma, B-Cell / immunology*
  • Molecular Sequence Data
  • Monocyte Chemoattractant Proteins / genetics*
  • Monocyte Chemoattractant Proteins / immunology
  • Polymerase Chain Reaction
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / immunology
  • Vaccines, DNA / immunology*

Substances

  • CCL7 protein, human
  • Cancer Vaccines
  • Chemokine CCL7
  • Cytokines
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • Monocyte Chemoattractant Proteins
  • Recombinant Fusion Proteins
  • Vaccines, DNA